Improving Targeted Delivery to Enhance Personalized Medicine - a podcast by Synthego

Andre Watson, CEO of Ligandal, talks about how his company is improving the payload delivery of gene therapy, making it more accurate and efficient, to make new gene therapy a reality for the public.

Further episodes of CRISPR Cuts

Further podcasts by Synthego

Website of Synthego